NYSE:ANTM - Anthem Stock Price, Forecast & News

Anthem trades on the New York Stock Exchange (NYSE) under the ticker symbol "ANTM."

Anthem announced a quarterly dividend on Wednesday, October 23rd. Investors of record on Thursday, December 5th will be paid a dividend of $0.80 per share on Friday, December 20th. This represents a $3.20 annualized dividend and a dividend yield of 1.17%. The ex-dividend date of this dividend is Wednesday, December 4th. View Anthem's Dividend History.

Anthem Inc (NYSE:ANTM) issued its earnings results on Wednesday, January, 29th. The company reported $3.88 earnings per share for the quarter, missing the consensus estimate of $3.90 by $0.02. The company earned $27.13 billion during the quarter, compared to the consensus estimate of $27.06 billion. Anthem had a net margin of 4.29% and a return on equity of 15.59%. The company's quarterly revenue was up 16.4% on a year-over-year basis. During the same period last year, the firm posted $2.44 EPS. View Anthem's Earnings History.

Anthem is scheduled to release their next quarterly earnings announcement on Wednesday, January 29th 2020. View Earnings Estimates for Anthem.

Anthem issued an update on its FY 2020 Pre-Market earnings guidance on Wednesday, January, 29th. The company provided earnings per share (EPS) guidance of 22.30 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $22.71. The company issued revenue guidance of $117-117 billion, compared to the consensus revenue estimate of $115.28 billion.

15 equities research analysts have issued 1 year target prices for Anthem's shares. Their forecasts range from $262.00 to $391.00. On average, they anticipate Anthem's share price to reach $334.64 in the next year. This suggests a possible upside of 22.7% from the stock's current price. View Analyst Price Targets for Anthem.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Anthem in the last year. There are currently 3 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Anthem.

News stories about ANTM stock have been trending very positive recently, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Anthem earned a news impact score of 3.3 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 2.0 out of 10, indicating that recent news coverage is very unlikely to have an impact on the stock's share price in the near term. View News Stories for Anthem.

Anthem saw a increase in short interest in January. As of January 15th, there was short interest totalling 4,400,000 shares, an increase of 13.1% from the December 31st total of 3,890,000 shares. Based on an average trading volume of 1,420,000 shares, the days-to-cover ratio is currently 3.1 days. Approximately 1.7% of the company's stock are sold short. View Anthem's Current Options Chain.

Some companies that are related to Anthem include UnitedHealth Group (UNH), Cigna (CI), Humana (HUM), Centene (CNC), WellCare Health Plans (WCG), Molina Healthcare (MOH), Magellan Health (MGLN) and Triple-S Management (GTS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Anthem investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), Alibaba Group (BABA), Walt Disney (DIS), Boeing (BA), Visa (V), AT&T (T), Netflix (NFLX), Bank of America (BAC) and CVS Health (CVS).

Anthem's stock is owned by a number of of institutional and retail investors. Top institutional investors include California Public Employees Retirement System (0.48%), M&G Investment Management Ltd. (0.25%), Focused Investors LLC (0.24%), New York State Teachers Retirement System (0.15%), Artemis Investment Management LLP (0.15%) and Strs Ohio (0.14%). Company insiders that own Anthem stock include Brian T Griffin, Craig E Samitt, Gloria M Mccarthy, John E Gallina, Joseph Swedish, Julie A Hill, Peter D Haytaian, Ramiro G Peru, Robert L Dixon Jr, Ronald W Penczek and Thomas C Zielinski. View Institutional Ownership Trends for Anthem.

ANTM stock was sold by a variety of institutional investors in the last quarter, including First Hawaiian Bank, Assenagon Asset Management S.A., Focused Investors LLC, California Public Employees Retirement System, DNB Asset Management AS, Braun Stacey Associates Inc., Meag Munich Ergo Kapitalanlagegesellschaft MBH and State of Alaska Department of Revenue. Company insiders that have sold Anthem company stock in the last year include Gloria M Mccarthy, Julie A Hill, Peter D Haytaian, Ramiro G Peru, Robert L Dixon Jr, Ronald W Penczek and Thomas C Zielinski. View Insider Buying and Selling for Anthem.

ANTM stock was bought by a variety of institutional investors in the last quarter, including M&G Investment Management Ltd., Mckinley Capital Management LLC Delaware, Empire Life Investments Inc., Artemis Investment Management LLP, British Airways Pensions Investment Management Ltd, Coronation Fund Managers Ltd., Campbell & CO Investment Adviser LLC and Duncker Streett & Co. Inc.. View Insider Buying and Selling for Anthem.

Shares of ANTM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ANTM stock can currently be purchased for approximately $272.76.

Anthem has a market capitalization of $69.16 billion and generates $92.11 billion in revenue each year. The company earns $3.75 billion in net income (profit) each year or $15.89 on an earnings per share basis. Anthem employs 63,900 workers across the globe.View Additional Information About Anthem.

The official website for Anthem is http://www.antheminc.com/.

Anthem's mailing address is 220 VIRGINIA AVENUE, INDIANAPOLIS IN, 46204. The company can be reached via phone at 800-331-1476 or via email at [email protected]